Immutep (IMMP) Depreciation & Amortization (CF) (2015 - 2024)
Immutep's (IMMP) quarterly Depreciation & Amortization (CF) came in at $1.5 million in Q2 2024, up 8.17% YoY from $1.4 million in Q3 2023, and up 8.17% on a QoQ basis from $1.4 million in Q2 2023.
Immutep (IMMP) Depreciation & Amortization (CF) (2015 - 2024) Analysis & Trends
Immutep (IMMP) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.5 million in Q2 2024.
- Quarterly Depreciation & Amortization (CF) rose 8.17% year-over-year to $1.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 48.04% YoY) and the FY2024 annual result came in at $1.5 million, up 8.17% from the prior year.
- Depreciation & Amortization (CF) climbed to $1.5 million in Q2 2024, from $1.4 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.5 million in Q2 2024 to a low of $1.4 million in Q2 2020.
- A 3-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2020 — Depreciation & Amortization (CF) advanced 3.55% — and 2024, when it climbed 8.17%.
- Tracing IMMP's Depreciation & Amortization (CF) over 3 years: stood at $1.4 million in 2020, then advanced by 1.1% to $1.4 million in 2023, then increased by 8.17% to $1.5 million in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $1.5 million (Q2 2024), $1.4 million (Q2 2023), and $1.4 million (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Jun 30, 2020 | 1.36 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Jun 30, 2017 | 1.28 Mn |
| Jun 30, 2017 | 1.28 Mn |
| Jun 30, 2016 | 1.49 Mn |
| Jun 30, 2016 | 1.49 Mn |
| Jun 30, 2015 | 1.04 Mn |
| Jun 30, 2015 | 1.04 Mn |